Company Filing History:
Years Active: 2023-2025
Title: Allen James Ebens, Jr: Innovator in Binding Agents
Introduction
Allen James Ebens, Jr. is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of binding agents. With a total of 2 patents to his name, his work has implications for therapeutic applications.
Latest Patents
Ebens' latest patents focus on ILT-binding agents and methods of use thereof. The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4. It also includes compositions comprising these binding agents and methods of their use. Additionally, the disclosure provides related polynucleotides and vectors encoding the binding agents, as well as cells comprising the binding agents.
Career Highlights
Ebens is currently associated with NGM Biopharmaceuticals, Inc., where he continues to innovate in the field of biopharmaceuticals. His work is crucial in advancing therapeutic strategies that target specific proteins involved in various diseases.
Collaborations
Some of his notable coworkers include Dana Yen Mei Duey and Daniel David Kaplan. Their collaborative efforts contribute to the innovative environment at NGM Biopharmaceuticals, Inc.
Conclusion
Allen James Ebens, Jr. is a prominent figure in the biopharmaceutical industry, recognized for his innovative work on ILT-binding agents. His contributions are paving the way for new therapeutic approaches in medicine.